← Eichor
Study identifier: NCT06382818 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Personalization of Breast Radiotherapy According to Loco-regional Recurrence Risk and Toxicity Probability

Condition: Breast Cancer  ·  Sponsor: Institut du Cancer de Montpellier - Val d'Aurelle

PhaseNA
Planned participants854
Who can joinFemale, 18 Years to no upper limit
Healthy volunteersNo

About this study

Our objective is based on a personalized approach of adjuvant breast radiotherapy by selecting patients according to tumor recurrence and toxicity risk.

This description comes directly from the study's public registry record.

Talk to the study team

MOUSSION AURORE  ·  0467613102  ·  aurore.moussion@icm.unicancer.fr

Always discuss trial participation with your own doctor first.

Locations (1)

Institut Du Cancer de MontpellierMontpellier, FranceRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06382818